Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.
Saved in:
| Title: | Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study. |
|---|---|
| Authors: | Scharl S; Department of Radiation Oncology, University Hospital Ulm, Germany. Electronic address: Sophia.scharl@uniklinik-ulm.de., Zamboglou C; Department of Radiation Oncology, Medical Center -Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Germany; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Germany; German Oncology Center, University Hospital of the European University, Limassol, Cyprus., Strouthos I; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus., Farolfi A; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Serani F; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Lanzafame H; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Radiation Oncology, Royal North Shore Hospital - University of Sydney, Australia., Giuseppe Morganti A; Division of Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Trapp C; Department of Radiation Oncology, University Hospital, LMU Munich, Germany., Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany., Peeken JC; Department of Radiation Oncology, Klinikum Rechts der Isar, Technical University of Munich (TUM), Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum, München, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Germany., Vogel MME; Department of Radiation Oncology, Klinikum Rechts der Isar, Technical University of Munich (TUM), Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum, München, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Germany., Vrachimis A; Department of Nuclear Medicine, German Oncology Center, University Hospital of the European University, Limassol, Cyprus; C.A.R.I.C. Cancer Research & Innovation Center, Limassol, Cyprus., Spohn SKB; Department of Radiation Oncology, Medical Center -Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Germany; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Germany., Ruf J; German Cancer Consortium (DKTK), Partner Site Freiburg, Germany; Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany., Grosu AL; Department of Radiation Oncology, Medical Center -Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Germany., Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy., Fendler WP; Department of Nuclear Medicine, University Hospital, LMU Munich, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany., Bartenstein P; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Switzerland., Kroeze SGC; Department of Radiation Oncology, University Hospital Ulm, Germany; Radiation Oncology Center KSA-KSB, Canton Hospital of Aarau, Aarau, Switzerland., Guckenberger M; Department of Radiation Oncology, University Hospital Ulm, Germany., Krafcsik M; Department of Radiation Oncology, University Hospital Ulm, Germany., Klopscheck C; University Hospital Ulm, Ulm, Germany., Fanti S; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Hruby G; Department of Radiation Oncology, Royal North Shore Hospital - University of Sydney, Australia., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia., Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Germany., Stief C; Department of Urology, University Hospital, LMU Munich, Germany., Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Germany., Henkenberens C; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany., Mayer B; Institute for Epidemiology and Medical Biometry, University Ulm, Ulm, Germany., Miksch J; Department of Nuclear Medicine, University Hospital Ulm, University Ulm, Ulm, Germany., Shelan M; Department of Radiation Oncology, Inselspital Bern, University of Bern, Switzerland., Aebersold DM; Department of Radiation Oncology, Inselspital Bern, University of Bern, Switzerland., Thamm R; Department of Radiation Oncology, University Hospital Ulm, Germany., Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Germany. |
| Source: | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Jul; Vol. 184, pp. 109678. Date of Electronic Publication: 2023 May 03. |
| Publication Type: | Multicenter Study; Journal Article |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
